Intuitive Surgical, Inc. (ISRG) Balance Sheet

The balance sheet is clearly strengthening, driven by strong profitability and cash generation. Equity grew from $14.0B in 2024Q1 to $18.2B in 2026Q2, a 30% increase, while total liabilities remained modest at $2.6B. This suggests the company is funding its expansion internally, with no reliance on debt, indicating a high-quality earnings trajectory.

The company's debt is negligible, appearing only briefly in 2024Q4 and 2025Q4, likely for short-term purposes. This debt-free status, combined with a current ratio above 4.8, suggests that leverage is not a strategic tool but rather a non-issue. Investors should view this as a fortress balance sheet that can withstand operational shocks without credit constraints.

The asset base is increasingly weighted toward PP&E, which now represents 27% of total assets, up from 24% in 2024Q1. This suggests a maturing capital-intensive phase, though the recent spike in goodwill from $348M to $580M in 2026Q2 warrants monitoring for potential impairment risk. The overall asset mix remains healthy, with intangibles still a small portion of the balance sheet.

Equity quality is high, with retained earnings being the primary driver of growth, reflecting consistent profitability. However, the company has initiated significant share repurchases totaling $3.0B in recent quarters, which may offset some dilution from stock-based compensation. The balance between buybacks and SBC will be key to preserving shareholder value.

Liquidity is exceptionally strong, with a current ratio consistently above 4.0 and cash reserves that cover a significant portion of total liabilities. This suggests the company can easily fund its operating expenses and capital expenditures without external financing. The cash position, though fluctuating, remains robust, supporting ongoing R&D and potential strategic initiatives.